JPRN-UMIN000011853
Completed
未知
Clinical study concerning anti-inflammatory effect of fixed dose therapy by budesonide/formoterol combination inhaler for moderate persistent asthmatics. - anti-inflammatory effect of BUD/FM inhaler
ational Center for Global Health and Medicine0 sites50 target enrollmentSeptember 25, 2013
ConditionsBronchial asthma
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Bronchial asthma
- Sponsor
- ational Center for Global Health and Medicine
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Current smokers, those who had a smoking history (smoking index \> 400\) and patients with suspected COPD were excluded
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical study to evaluate anti-inflammatory effects of intravenous azithromycin add-on therapy for the treatment of bacterial pneumonia.PneumoniaJPRN-UMIN000008010Yokohama City University Medical Center80
Recruiting
Phase 3
A study on therapeutic and anti-inflammatory effects of probiotic in asthmatic patients referred to kowsar semnan hospitalAsthmatic.Mild intermittent asthma with status asthmaticusJ45.22IRCT20151228025732N54Semnan University of Medical Sciences60
Completed
Phase 3
nani Modality(Bukhoor therapy) and its Efficacy in Low back pain management.CTRI/2022/10/046531Ajmal khan Tibbiya college60
Completed
Phase 1
Evaluation of efficacy and anti-inflammatory action of PlacentrexTM in women with inflammatory Pap smears.CTRI/2010/091/000197ALBERT DAVID LTD KOLKATA150
Active, not recruiting
Not Applicable
ntersuchung der antiinflammatorischen Eigenschaften von Clopidogrel im Vergleich zu Acetylsalicylsäure bei Patienten mit chronischer ischämischer KardiomyopathieDas Ziel dieser Untersuchung ist es, zu evaluieren, ob und welche antiinflammatorischen Effekte Clopidogrel 75 mg im Vergleich zu Acetylalicylsäure (ASS) 100 mg bei Patienten mit chronischer ischämischer Kardiomyopathie aufweist. Untersucht werden soll dieses mittels Evaluation der peripheren endothelialen Stickstoffmonoxid-(NO) Bioverfügbarkeit sowie durch Bestimmung der Spiegel zirkulierender Peroxidasen wie Myeloperoxidase (MPO) oder Xanthin Oxidase (XO).EUCTR2006-000001-27-DEniversitäres Herzzentrum, Klinik für Kardiologie und Angiologie